It is therefore reasonable to hypothesize that serial post-transplant Th1, Th2 subsets and associated cytokines (including IFN-γ, IL-12, IL-4 and IL-10) monitoring may elucidate the immunological network of GVHD and thus improve our management of GVHD. The gene discussed is IFNG; the disease is graft versus host disease.